Equities Research Analysts’ price target changes for Monday, September 22nd:
AbbVie (NYSE:ABBV) had its target price increased by Evercore ISI from $207.00 to $222.00. They currently have an outperform rating on the stock.
Albemarle (NYSE:ALB) had its price target boosted by HSBC Holdings plc from $60.00 to $75.00. They currently have a hold rating on the stock.
Barrick Mining (NYSE:B) (TSE:ABX) had its price target increased by CIBC from $30.00 to $38.00. They currently have an outperformer rating on the stock.
Barrick Mining (NYSE:B) (TSE:ABX) had its target price increased by Raymond James Financial, Inc. from $32.00 to $36.00. Raymond James Financial, Inc. currently has an outperform rating on the stock.
Beta Bionics (NASDAQ:BBNX) had its target price boosted by Truist Financial Corporation from $21.00 to $28.00. They currently have a buy rating on the stock.
Baidu (NASDAQ:BIDU) had its target price raised by Nomura from $91.00 to $135.00. The firm currently has a neutral rating on the stock.
BioNTech (NASDAQ:BNTX) had its price target increased by JPMorgan Chase & Co. from $116.00 to $121.00. They currently have a neutral rating on the stock.
Popular (NASDAQ:BPOP) had its price target increased by Wells Fargo & Company from $140.00 to $150.00. They currently have an overweight rating on the stock.
Caterpillar (NYSE:CAT) had its target price raised by Citigroup Inc. from $500.00 to $540.00.
Celtic (LON:CCP) had its target price boosted by Canaccord Genuity Group Inc. from GBX 208 to GBX 212. They currently have a buy rating on the stock.
Cidara Therapeutics (NASDAQ:CDTX) had its target price boosted by WBB Securities from $45.00 to $123.00. WBB Securities currently has a strong-buy rating on the stock.
Comcast (NASDAQ:CMCSA) had its target price reduced by Loop Capital from $50.00 to $44.00. The firm currently has a buy rating on the stock.
ConocoPhillips (NYSE:COP) had its target price boosted by BMO Capital Markets from $113.00 to $115.00. BMO Capital Markets currently has an outperform rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target increased by Canaccord Genuity Group Inc. from $430.00 to $500.00. Canaccord Genuity Group Inc. currently has a hold rating on the stock.
CVS Health (NYSE:CVS) had its price target increased by Wolfe Research from $80.00 to $85.00. The firm currently has an outperform rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its target price increased by B. Riley from $74.00 to $80.00. B. Riley currently has a buy rating on the stock.
DuPont de Nemours (NYSE:DD) had its target price raised by KeyCorp from $92.00 to $93.00. The firm currently has an overweight rating on the stock.
EQT (NYSE:EQT) had its price target reduced by BMO Capital Markets from $62.00 to $60.00. They currently have an outperform rating on the stock.
FedEx (NYSE:FDX) had its target price raised by Sanford C. Bernstein from $247.00 to $250.00. The firm currently has a market perform rating on the stock.
FedEx (NYSE:FDX) had its price target boosted by Daiwa Capital Markets from $232.00 to $240.00. Daiwa Capital Markets currently has a neutral rating on the stock.
FrontView REIT (NYSE:FVR) had its price target boosted by JPMorgan Chase & Co. from $12.00 to $15.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
GE Aerospace (NYSE:GE) had its target price raised by Jefferies Financial Group Inc. from $320.00 to $350.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Glaukos (NYSE:GKOS) had its price target trimmed by Truist Financial Corporation from $126.00 to $120.00. Truist Financial Corporation currently has a buy rating on the stock.
Alphabet (NASDAQ:GOOG) had its target price raised by Robert W. Baird from $215.00 to $275.00. They currently have an outperform rating on the stock.
Alphabet (NASDAQ:GOOGL) had its target price boosted by Truist Financial Corporation from $225.00 to $285.00. The firm currently has a buy rating on the stock.
Alphabet (NASDAQ:GOOGL) had its target price boosted by Robert W. Baird from $215.00 to $275.00. They currently have an outperform rating on the stock.
GRI Bio (NASDAQ:GRI) had its target price boosted by Ascendiant Capital Markets from $34.00 to $35.00. The firm currently has a buy rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its target price increased by HC Wainwright from $75.00 to $85.00. HC Wainwright currently has a buy rating on the stock.
Hesai Group (NASDAQ:HSAI) had its target price raised by The Goldman Sachs Group, Inc. from $26.30 to $36.00. The firm currently has a buy rating on the stock.
Host Hotels & Resorts (NASDAQ:HST) had its price target raised by UBS Group AG from $17.00 to $18.00. They currently have a neutral rating on the stock.
Heartflow (NASDAQ:HTFL) had its target price increased by Canaccord Genuity Group Inc. from $35.00 to $39.00. They currently have a buy rating on the stock.
International Flavors & Fragrances (NYSE:IFF) had its price target reduced by Morgan Stanley from $92.00 to $90.00. Morgan Stanley currently has an overweight rating on the stock.
IMAX (NYSE:IMAX) had its price target raised by Wedbush from $35.00 to $39.00. They currently have an outperform rating on the stock.
IonQ (NYSE:IONQ) had its target price boosted by B. Riley from $75.00 to $100.00. B. Riley currently has a buy rating on the stock.
Jasper Therapeutics (NASDAQ:JSPR) had its price target trimmed by Evercore ISI from $20.00 to $14.00. The firm currently has an outperform rating on the stock.
Jasper Therapeutics (NASDAQ:JSPR) had its target price trimmed by JMP Securities from $12.00 to $6.00. JMP Securities currently has a market outperform rating on the stock.
Jasper Therapeutics (NASDAQ:JSPR) had its target price trimmed by BTIG Research from $20.00 to $7.00. BTIG Research currently has a buy rating on the stock.
Kimberly-Clark (NYSE:KMB) had its target price reduced by Evercore ISI from $155.00 to $150.00. They currently have an outperform rating on the stock.
Lennar (NYSE:LEN) had its price target cut by JPMorgan Chase & Co. from $97.00 to $92.00. The firm currently has a neutral rating on the stock.
Lennar (NYSE:LEN) had its price target increased by Royal Bank Of Canada from $98.00 to $106.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Lennar (NYSE:LEN) had its target price increased by Evercore ISI from $114.00 to $118.00. The firm currently has an in-line rating on the stock.
Lumentum (NASDAQ:LITE) had its target price boosted by Rosenblatt Securities from $150.00 to $225.00. Rosenblatt Securities currently has a buy rating on the stock.
Lattice Semiconductor (NASDAQ:LSCC) had its target price boosted by Needham & Company LLC from $70.00 to $80.00. They currently have a buy rating on the stock.
Lyft (NASDAQ:LYFT) had its target price boosted by Benchmark Co. from $20.00 to $26.00. The firm currently has a buy rating on the stock.
MongoDB (NASDAQ:MDB) had its target price increased by Canaccord Genuity Group Inc. from $340.00 to $375.00. The firm currently has a buy rating on the stock.
MGM Resorts International (NYSE:MGM) had its target price cut by Mizuho from $58.00 to $56.00. The firm currently has an outperform rating on the stock.
Myomo (NYSEAMERICAN:MYO) had its target price cut by Ascendiant Capital Markets from $11.50 to $10.50. Ascendiant Capital Markets currently has a buy rating on the stock.
NioCorp Developments (NASDAQ:NB) had its target price increased by HC Wainwright from $4.00 to $8.25. HC Wainwright currently has a buy rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its price target boosted by Needham & Company LLC from $161.00 to $170.00. Needham & Company LLC currently has a buy rating on the stock.
Oncobiologics (NASDAQ:OTLK) had its price target cut by Ascendiant Capital Markets from $21.00 to $8.00. The firm currently has a buy rating on the stock.
Paychex (NASDAQ:PAYX) had its price target cut by Stifel Nicolaus from $152.00 to $142.00. The firm currently has a hold rating on the stock.
Pets at Home Group (LON:PETS) had its price target cut by Canaccord Genuity Group Inc. from GBX 285 to GBX 245. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Plexus (NASDAQ:PLXS) had its target price boosted by Benchmark Co. from $160.00 to $165.00. Benchmark Co. currently has a buy rating on the stock.
PPHE Hotel Group (LON:PPH) had its price target cut by Jefferies Financial Group Inc. from GBX 1,700 to GBX 1,600. The firm currently has a buy rating on the stock.
Phillips 66 (NYSE:PSX) had its target price increased by UBS Group AG from $143.00 to $150.00. The firm currently has a buy rating on the stock.
D-Wave Quantum (NYSE:QBTS) had its target price increased by B. Riley from $22.00 to $33.00. They currently have a buy rating on the stock.
Roblox (NYSE:RBLX) had its price target boosted by JPMorgan Chase & Co. from $150.00 to $160.00. The firm currently has an overweight rating on the stock.
Rigetti Computing (NASDAQ:RGTI) had its target price boosted by B. Riley from $19.00 to $35.00. B. Riley currently has a buy rating on the stock.
Avidity Biosciences (NASDAQ:RNA) had its target price trimmed by Evercore ISI from $70.00 to $65.00. The firm currently has an outperform rating on the stock.
Super Group (SGHC) (NYSE:SGHC) had its target price increased by JMP Securities from $15.00 to $16.00. JMP Securities currently has a market outperform rating on the stock.
Sintx Technologies (NASDAQ:SINT) had its target price lowered by Ascendiant Capital Markets from $28.00 to $25.00. The firm currently has a buy rating on the stock.
Beauty Health (NASDAQ:SKIN) had its target price increased by TD Cowen from $2.00 to $2.50. The firm currently has a hold rating on the stock.
Seagate Technology (NASDAQ:STX) had its price target increased by Cantor Fitzgerald from $175.00 to $280.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Tesla (NASDAQ:TSLA) had its price target raised by Piper Sandler from $400.00 to $500.00. The firm currently has an overweight rating on the stock.
United Rentals (NYSE:URI) had its target price raised by JPMorgan Chase & Co. from $1,000.00 to $1,150.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Valero Energy (NYSE:VLO) had its price target increased by UBS Group AG from $165.00 to $183.00. UBS Group AG currently has a buy rating on the stock.
Warner Bros. Discovery (NASDAQ:WBD) had its target price raised by Moffett Nathanson from $14.00 to $23.00. The firm currently has a buy rating on the stock.
Zeta Global (NYSE:ZETA) had its price target boosted by DA Davidson from $25.00 to $27.00. DA Davidson currently has a buy rating on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
